- Home
- CNTX vs FGNX Comparison
CNTX vs FGNX Comparison
Compare CNTX & FGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNTX | FGNX |
|---|---|---|
| Founded | 2015 | 1932 |
| Country | United States | United States |
| Employees | 15 | 15 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.5M | 44.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNTX | FGNX |
|---|---|---|
| Price | $0.59 | $5.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $6.60 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 2.7M | 100.2K |
| Earning Date | 05-08-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $650.31 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.55 | $1.59 |
| 52 Week High | $3.62 | $18.42 |
Technical Indicators
Market Signals| Indicator | CNTX | FGNX |
|---|---|---|
| Relative Strength Index (RSI) | 20.39 | 44.18 |
| Support Level | N/A | $5.71 |
| Resistance Level | $1.30 | $7.65 |
| Average True Range (ATR) | 0.14 | 0.67 |
| MACD | -0.05 | -0.10 |
| Stochastic Oscillator | 3.80 | 28.30 |
Price Performance
Historical ComparisonAbout CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About FGNX Fundamental Global Inc.
FG Nexus Inc operates through two primary segments: Digital Assets and Merchant Banking, with Digital Assets contributing the majority of revenue. The Company functions as a digital asset treasury, mainly holding Ethereum (ETH) and exploring opportunities in the tokenization of real-world assets, leveraging ETH as the foundation for digital finance, stablecoins, DeFi, and tokenized assets. The Merchant Banking segment offers strategic, administrative, and regulatory support to newly formed SPACs through the Company's SPAC platform.